Light Mode
$1.24 ↓ -0.01 (-0.80%) Trading Down from the previous close of $1.25, $0.01 below the day’s high of $1.25
-2.76 (-69.87%) / 6M
Momentum, market sentiment, and recent alerts
CATX reads not so good: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -58.5%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.